Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas.
about
Galectin-3 as a regulator of the epithelial junction: Implications to wound repair and cancerCadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumourA quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinomaKnockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo.Neoadjuvant treatment for resectable pancreatic adenocarcinoma.Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinomaLiver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesisTargeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer.Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.Involvement of liver-intestine cadherin in cancer progression.Possible roles of LI-Cadherin in the formation and maintenance of the intestinal epithelial barrier.Down-regulation of liver-intestine cadherin enhances noscapine-induced apoptosis in human colon cancer cells.Expression of cadherin 17 in well-differentiated neuroendocrine tumours.Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis.Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA.Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.Downregulation of liver-intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells.CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm.Fluorescent Indolylboronic Acids that are Useful Reporters for the Synthesis of BoronolectinsSerine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
P2860
Q26785535-C9C0D932-01C1-446F-BE03-E8BC6301CA1BQ34995751-26104779-D962-4BF7-914A-E3DF9FBBC064Q35790227-CD92A33D-5EA4-49C7-8E52-43CAD2C9FE9DQ35893965-3C138081-00F8-49BB-9ED6-853FE97506CAQ36066837-FB711246-6C05-4534-9E44-5D175B758CEFQ36526141-993A4C6E-F51B-4513-94D9-FEA8F728D7C9Q36529179-0DC0DC45-51E0-4E96-8DC5-0421C931C93AQ36739396-3258B169-79B3-452E-98D4-5D34266616F0Q37495777-5E1DBE5B-3331-4308-ADC5-34765A5644B7Q37885319-5713176B-40EC-4232-8897-A406579EA80CQ38073099-5813B9AA-BA3A-48F6-92B7-37245BA42AD8Q38199099-0C0295D2-DDAA-497D-9995-F91CA6807B4FQ38700109-CDADAD80-C26F-4CFF-898E-AF21F4B07D7EQ39129339-D1297ACB-FF9D-4DBA-9AE0-4295BECA427EQ39162923-5F4FCABE-F338-4615-9708-B2DAA9E06338Q39714510-2E6F4C5A-3D4B-438E-B8A0-52C560A10B0AQ47099168-9D7217A3-7424-4D77-A1A7-DB73E521DD51Q47331787-7D563A60-538E-4C36-8F31-DEED070C1EDAQ52904010-B1E11BD8-90C5-4E1E-9AF8-5C1C4BD5F956Q53275154-61F6641B-5F1A-46F3-8444-80ABE36BEFBCQ57697095-3D350A0E-57E0-47D9-B57B-311EE44B50F9Q58062853-92F0DA22-7A82-4A19-97A5-510FB9C324E6
P2860
Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@ast
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@en
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@nl
type
label
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@ast
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@en
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@nl
prefLabel
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@ast
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@en
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@nl
P2093
P2860
P1433
P1476
Expression of liver-intestine ...... denocarcinoma of the pancreas.
@en
P2093
Hitoshi Asakura
Masaaki Takamura
Michiie Sakamoto
Setsuo Hirohashi
Takafumi Ichida
Takeshi Shimamura
Yoshinori Ino
P2860
P304
P356
10.1111/J.1349-7006.2003.TB01459.X
P577
2003-05-01T00:00:00Z